{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T22:02:44Z","timestamp":1757628164101,"version":"3.44.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The clinical manifestations of dengue are well-described, but ocular involvement is being increasingly recognized and alterations to the natural trajectory of disease, including protracted viraemia, have also been recognized in immunocompromised patients. We describe a case of dengue in a lung transplant recipient which manifested predominantly as ocular symptoms following short-lived systemic features, and with protracted viraemia with delayed IgM to IgG seroconversion.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation<\/jats:title>\n            <jats:p>A 40-year-old woman who had a bilateral lung transplant 15 years prior for cystic fibrosis presented with headaches, bilateral scotomata and rapidly deteriorating visual acuity. She had recently travelled to Bali where she experienced a short-lived febrile illness featuring a retro-orbital headache and generalized arthralgia. Ocular examination demonstrated bilateral cystoid macular oedema, retinitis and retinal vasculitis. Dengue serotype 1 RNA was detected in serum, urine and aqueous humour samples. Dengue serology showed positive NS1 and IgM, and negative IgG. She had presented 14 days after the initial febrile illness began. High-dose prednisolone was commenced for the macular oedema, but this was stopped when low-grade fevers and arthralgias developed. Her immunosuppression was reduced, with clinical improvement to visual acuity and macular oedema observed, but high-dose prednisolone was recommenced at day 36 of illness due to new retinal haemorrhages, this time well-tolerated, with subsequent dose tapering. Viraemia was protracted, clearing at day 69, and IgG seroconversion was noted on day 319. Her vision improved sufficiently to allow driving and return to part-time work, though she continues to experience persisting symptomatic right-sided macular oedema.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This was an unusual presentation of dengue involving an immune-privileged site in an immunocompromised host. The competing priorities of facilitating immune-mediated clearance of viraemia versus controlling ocular inflammation posed a significant therapeutic challenge. A greater understanding of the pathophysiology of dengue eye disease, including virus-mediated and immune-mediated factors, as well as the development of therapeutic options, is critically required.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12879-025-11456-7","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T17:33:39Z","timestamp":1755192819000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prolonged dengue viremia with predominantly ocular manifestations in a lung transplant recipient"],"prefix":"10.1186","volume":"25","author":[{"given":"Leong Shuen","family":"Loo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Wells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noor","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Marr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"issue":"10169","key":"11456_CR1","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S0140-6736(18)32560-1","volume":"393","author":"A Wilder-Smith","year":"2019","unstructured":"Wilder-Smith A, Ooi EE, Horstick O, Wills B. Dengue. Lancet. 2019;393(10169):350\u201363. https:\/\/doi.org\/10.1016\/S0140-6736(18)32560-1.","journal-title":"Lancet."},{"issue":"6","key":"11456_CR2","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/ICU.0000000000000613","volume":"30","author":"T Somkijrungroj","year":"2019","unstructured":"Somkijrungroj T, Kongwattananon W. Ocular manifestations of dengue. Curr Opin Ophthalmol. 2019;30(6):500\u20135. https:\/\/doi.org\/10.1097\/ICU.0000000000000613.","journal-title":"Curr Opin Ophthalmol."},{"issue":"4","key":"11456_CR3","doi-asserted-by":"publisher","first-page":"e12721","DOI":"10.1111\/tid.12721","volume":"19","author":"BB de Souza Pereira","year":"2017","unstructured":"de Souza Pereira BB, Darrigo Junior LG, de Mello Costa TC, Felix AC, Simoes BP, Stracieri AB, et al. Prolonged viremia in dengue virus infection in hematopoietic stem cell transplant recipients and patients with hematological malignancies. Transpl Infect Disease. 2017;19(4):e12721. https:\/\/doi.org\/10.1111\/tid.12721.","journal-title":"Transpl Infect Disease."},{"issue":"5","key":"11456_CR4","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.chom.2019.10.005","volume":"26","author":"KH Ng","year":"2019","unstructured":"Ng KH, Zhang SL, Tan HC, Kwek SS, Sessions OM, Chan CY, et al. Persistent Dengue Infection in an Immunosuppressed Patient Reveals the Roles of Humoral and Cellular Immune Responses in Virus Clearance. Cell Host Microbe. 2019; 26(5):601-605.e3. https:\/\/doi.org\/10.1016\/j.chom.2019.10.005.","journal-title":"Cell Host Microbe"},{"issue":"3","key":"11456_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/tropicalmed3030075","volume":"3","author":"AT Pyke","year":"2018","unstructured":"Pyke AT, Gunn W, Taylor C, Mackay IM, McMahon J, Jelley L, et al. On the Home Front: Specialised Reference Testing for Dengue in the Australasian Region. Tropical Medicine and Infectious Disease. 2018;3(3):75. https:\/\/doi.org\/10.3390\/tropicalmed3030075.","journal-title":"Tropical Medicine and Infectious Disease"},{"issue":"2","key":"11456_CR6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3201\/eid1202.050274","volume":"12","author":"DP Chan","year":"2006","unstructured":"Chan DP, Teoh SC, Tan CS, Nah GK, Rajagopalan R, Prabhakaragupta MK, et al. Ophthalmic complications of dengue. Emerg Infect Dis. 2006;12(2):285\u20139. https:\/\/doi.org\/10.3201\/eid1202.050274.","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"11456_CR7","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1016\/j.ophtha.2004.03.038","volume":"111","author":"WK Lim","year":"2004","unstructured":"Lim WK, Mathur R, Koh A, Yeoh R, Chee SP. Ocular Manifestations of Dengue Fever. Ophthalmology. 2004;111(11):2057\u201364. https:\/\/doi.org\/10.1016\/j.ophtha.2004.03.038.","journal-title":"Ophthalmology"},{"issue":"3","key":"11456_CR8","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/IAE.0b013e3181bd2fc6","volume":"30","author":"SC Teoh","year":"2010","unstructured":"Teoh SC, Chee CK, Laude A, Goh KY, Barkham T, Ang BS. Optical coherence tomography patterns as predictors of visual outcome in dengue-related maculopathy. Retina. 2010;30(3):390\u20138. https:\/\/doi.org\/10.1097\/IAE.0b013e3181bd2fc6.","journal-title":"Retina"},{"issue":"5","key":"11456_CR9","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s10096-019-03792-9","volume":"39","author":"PAN da Silva","year":"2020","unstructured":"da Silva PAN, Malveste Ito CR, Barbosa MS, Santos MO, Carneiro LC. Arboviruses (chikungunya, dengue, and Zika) associated with ophthalmic changes: a focus on aqueous fluid and vitreous humor. Eur J Clin Microbiol Infect Dis. 2020;39(5):827\u201333. https:\/\/doi.org\/10.1007\/s10096-019-03792-9.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"11456_CR10","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.ajo.2009.06.030","volume":"148","author":"E Chee","year":"2009","unstructured":"Chee E, Sims JL, Jap A, Tan BH, Oh H, Chee SP. Comparison of prevalence of dengue maculopathy during two epidemics with differing predominant serotypes. Am J Ophthalmol. 2009;148(6):910\u20133. https:\/\/doi.org\/10.1016\/j.ajo.2009.06.030.","journal-title":"Am J Ophthalmol."},{"key":"11456_CR11","doi-asserted-by":"publisher","unstructured":"Carr JM, Ashander LM, Calvert JK, Ma Y, Aloia A, Bracho GG, et al. Molecular Responses of Human Retinal Cells to Infection with Dengue Virus. Mediators Inflamm. 2017;2017:3164375. https:\/\/doi.org\/10.1155\/2017\/3164375.","DOI":"10.1155\/2017\/3164375"},{"key":"11456_CR12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ijid.2020.09.1446","volume":"101","author":"P Matangkasombut","year":"2020","unstructured":"Matangkasombut P, Manopwisedjaroen K, Pitabut N, Thaloengsok S, Suraamornkul S, Yingtaweesak T, et al. Dengue viremia kinetics in asymptomatic and symptomatic infection. Int J Infect Dis. 2020;101:90\u20137. https:\/\/doi.org\/10.1016\/j.ijid.2020.09.1446.","journal-title":"Int J Infect Dis"},{"issue":"7","key":"11456_CR13","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3390\/v16070998","volume":"16","author":"GI Butel-Simoes","year":"2024","unstructured":"Butel-Simoes GI, Bajaj N, Asad S, Moselen J, Orlando N, Steinig E, et al. Neuro-Ophthalmic Dengue Infection: A Case Report with a Multiple Body Site Sampling Strategy and Review of Laboratory Data. Viruses. 2024; 16(7):998. https:\/\/doi.org\/10.3390\/v16070998","journal-title":"Viruses"},{"issue":"3","key":"11456_CR14","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3390\/v15030705","volume":"15","author":"MF Lee","year":"2023","unstructured":"Lee MF, Wu YS, Poh CL. Molecular mechanisms of antiviral agents against dengue virus. Viruses. 2023;15(3):705. https:\/\/doi.org\/10.3390\/v15030705.","journal-title":"Viruses"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11456-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11456-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11456-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T05:51:43Z","timestamp":1757483503000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11456-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11456"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11456-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written consent was obtained from the patient to participate in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent was obtained from the patient for publication of the study findings.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1023"}}